The molecular cloning of the cDNA and gene encoding the venal cell carcinom
a (RCC)-associated protein G250 is described. This protein is one of the be
st markers for clear cell RCC: all clear-cell RCC express this protein, whe
reas no expression can be detected in normal kidney and most other normal t
issue. Antibody studies have indicated that this molecule might serve as a
therapeutic target. In view of the induction/up-regulation of G250 antigen
in RCC, its restricted tissue expression and its possible role in therapy,
we set out to molecularly define the G250 antigen, which we identified as a
transmembrane protein identical to the tumor-associated antigen MN/CAIX. W
e determined, by FISH analysis, that the G250/MN/CAIX gene is located on ch
romosome 9p12-13. In view of the relative immunogenicity of RCC, we investi
gated whether the G250 antigen can be recognized by TIL derived from RCC pa
tients. The initial characterization of 18 different TIL cultures suggests
that anti-G250 reactivity is rare. (C) 2000 Wiley-Liss, Inc.